E-LIB Suche - Ergebnisse für: Antonio J Carcas

1

ALDRESS: A Retrospective Pilot Study to Develop a Pharmacol..:

Stewart, Stefan ; Gómez López de las Huertas, Arturo ; Jiménez-González, María...
Journal of Clinical Medicine. 13 (2024) 9 - p. 2622 , 2024

Link: https://doi.org/10.3390/..

2

Results of phase 2 randomized multi-center study to evaluat..:

Ferreras, Cristina ; Hernández-Blanco, Clara ; Martín-Quirós, Alejandro...
Cytotherapy. 26 (2024) 1 - p. 25-35 , 2024

Link: https://doi.org/10.1016/..

3

2383. Immunogenicity and reactogenicity of a first booster ..:

Salmanton-Garcia, Jon ; Neuhann, Julia M ; Stemler, Jannik...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

A Phase II Randomized Multi-Center Study to Evaluate the Sa..:

Perez-Martinez, Antonio ; Ferreras, Cristina ; Hernandez, Clara...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S63-S64 , 2023

Link: https://doi.org/10.1016/..

5

No changes in hemostasis after COVID-19–heterologous vaccin..:

Butta, Nora V. ; Arias-Salgado, Elena G. ; Monzón Manzano, Elena...
Research and Practice in Thrombosis and Haemostasis. 7 (2023) 1 - p. 100049 , 2023

Link: https://doi.org/10.1016/..

6

IMUNOGENICIDADE DE UM PRIMEIRO REFORÇO COM BNT162B2 OU MRNA..:

Salmanton-Garcia, Jon ; Neuhann, Julia M. ; Stemler, Jannik...
The Brazilian Journal of Infectious Diseases. 27 (2023) - p. 102925 , 2023

Link: https://doi.org/10.1016/..

7

Identifying biomarkers of treatment response to ciclosporin..:

Marín-Candón, Alicia ; García-García, Irene ; Arias, Pedro...
BMJ Open. 13 (2023) 7 - p. e072350 , 2023

Link: https://doi.org/10.1136/..

8

Advancing pharmacogenetic testing in a tertiary hospital: a..:

Stewart, Stefan ; Dodero-Anillo, Jose Manuel ; Guijarro-Eguinoa, Javier...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Academia and industry agreement on a feasibility tool for f..:

Moraga, Paloma ; Prieto, Paula ; Conradie, Almari...
Clinical and Translational Science. 16 (2023) 12 - p. 2421-2428 , 2023

Link: https://doi.org/10.1111/..

10

Immunogenicity and reactogenicity of a first booster with B..:

Neuhann, Julia M. ; Stemler, Jannik ; Carcas, Antonio J....
Vaccine. 41 (2023) 48 - p. 7166-7175 , 2023

Link: https://doi.org/10.1016/..

11

Evaluation of factors associated with recruitment rates in ..:

Moraga Alapont, Paloma ; Prieto, Paula ; Urroz, Mikel...
Clinical and Translational Science. 16 (2023) 12 - p. 2654-2664 , 2023

Link: https://doi.org/10.1111/..

12

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Hea..:

García-García, Irene ; Seco-Meseguer, Enrique ; Ruiz-Seco, Pilar...
Journal of Clinical Medicine. 11 (2022) 4 - p. 1139 , 2022

Link: https://doi.org/10.3390/..

13

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib..:

Montejano, Rocío ; de la Calle-Prieto, Fernando ; Velasco, María...
Clinical Infectious Diseases. 76 (2022) 3 - p. e116-e125 , 2022

Link: https://doi.org/10.1093/..

14

Anti-cancer drug combinations approved by US FDA from 2011 ..:

Fudio, Salvador ; Sellers, Alvaro ; Pérez Ramos, Laura...
Cancer Chemotherapy and Pharmacology. 90 (2022) 4 - p. 285-299 , 2022

Link: https://doi.org/10.1007/..

15

Rapid, scalable assessment of SARS-CoV-2 cellular immunity ..:

Schwarz, Megan ; Torre, Denis ; Lozano-Ojalvo, Daniel...
Nature Biotechnology. , 2022

Link: https://doi.org/10.1038/..